Sex | Age (y) | 10 year cumulative risk (%) | ||||
Main analysis Q = 0.85 D = 3.6y | One-way sensitivity analyses | |||||
Q = 0.70 | Q = 1.00 | D = 2y | D = 5y | |||
Women | 55 | 25.4 | 21.5 | 29.2 | 22.9 | 27.3 |
60 | 31.2 | 26.5 | 35.6 | 28.1 | 33.5 | |
65 | 36.2 | 31.0 | 41.1 | 33.4 | 38.3 | |
70 | 41.0 | 35.2 | 46.2 | 38.1 | 43.0 | |
75 | 43.3 | 37.4 | 48.7 | 41.8 | 44.5 | |
80 | 42.9 | 37.0 | 48.3 | 42.7 | 43.0 | |
Men | 55 | 25.2 | 21.3 | 29.0 | 22.5 | 27.2 |
60 | 30.7 | 26.1 | 35.0 | 27.9 | 32.7 | |
65 | 33.9 | 28.9 | 38.6 | 32.4 | 35.1 | |
70 | 35.2 | 30.0 | 40.0 | 34.3 | 35.8 | |
75 | 38.0 | 32.5 | 43.0 | 36.9 | 38.7 | |
80 | 39.7 | 34.0 | 44.8 | 38.9 | 40.2 |
The proportion of colorectal cancers (CRC) arising from polypoid adenomas Q and the duration from CRC onset to CRC detection D are set to 0.85 and 3.6 years, respectively, in the main analyses, and they are varied between 0.7 and 1.0 and between 2 and 5 years, respectively, in the sensitivity analyses.